✦ LIBER ✦

145 PP2A – a Novel Target for the Treatment of Lapatinib-resistant Breast Cancer

✍ Scribed by McDermott, M.S.; Browne, B.C.; O'Brien, N.A.; Slamon, D.J.; Henry, M.; Meleady, P.; Clynes, M.; Dowling, P.; Crown, J.; O'Donovan, N.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

144 Alterations in Apoptosis-related Gen

✍ Eustace, A.J.; Browne, B.C.; McDermott, M.; O'Leary, P.; O'Driscoll, L.; O'Brien 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Nek2 as a novel molecular target for the

✍ Nobuyuki Tsunoda; Toshio Kokuryo; Koji Oda; Takeshi Senga; Yukihiro Yokoyama; Ma 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 369 KB

A phase II study of lapatinib and bevaci

✍ Hope S. Rugo, A. Jo Chien, Sandra X. Franco, Alison T. Stopeck, Alexa Glencer, S 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 271 KB

Phase II trial of a novel capecitabine d

✍ Devika Gajria; Joseph Gonzalez; Kimberly Feigin; Sujata Patil; Carol Chen; Maria 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 219 KB

The hedgehog pathway as a therapeutic ta

✍ M. F. Barginear; M. Leung; D. R. Budman 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 276 KB

Bcl-2 antisense oligonucleotides: a pote

✍ Rita Nahta; Francisco J Esteva 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 157 KB